Data:
{
"symbol": "NBIX",
"price": 135.93,
"marketCap": 13817148570,
"beta": 0.4,
"lastDividend": 0,
"range": "122.14-186.12",
"change": 0.22,
"changePercentage": 0.16211,
"volume": 204583.20632,
"averageVolume": 1274767,
"companyName": "Neurocrine Biosciences, Inc.",
"currency": "USD",
"cik": "0000914475",
"isin": "US64125C1099",
"cusip": "64125C109",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.neurocrine.com",
"description": "Neurocrine Biosciences, Inc. is a pharmaceutical firm dedicated to the creation, advancement, and commercialization of medicines addressing a spectrum of neurological, endocrine, and psychiatric conditions. Its current therapeutic pipeline and marketed products target disorders such as tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, alongside numerous experimental compounds in various clinical stages. The company's primary commercial asset is INGREZZA, a VMAT2 inhibitor indicated for the management of tardive dyskinesia. Other available treatments include ONGENTYS, which serves as an auxiliary therapy for individuals with Parkinson's disease who are also receiving levodopa/DOPA decarboxylase inhibitors; ORILISSA, prescribed for the alleviation of moderate to severe pain linked with endometriosis in women; and ORIAHNN, an oral, non-surgical option for pre-menopausal women experiencing significant menstrual bleeding associated with uterine fibroids. Furthermore, Neurocrine is actively progressing a number of drug candidates through clinical development. These include NBI-921352 for treating pediatric patients and adult focal epilepsy; NBI-827104, designed to address rare pediatric epilepsy and essential tremor; NBI-1065845 for major depressive disorder; NBI-1065846 specifically for anhedonia within major depressive disorder; and NBI-118568 for the treatment of schizophrenia. The company also maintains strategic licensing and collaborative ventures with partners such as Heptares Therapeutics Limited, Takeda Pharmaceutical Company Limited, Idorsia Pharmaceuticals Ltd, Xenon Pharmaceuticals Inc., Voyager Therapeutics, Inc., BIAL Portela & Ca, S.A., Mitsubishi Tanabe Pharma Corporation, and AbbVie Inc. Neurocrine Biosciences, Inc. was founded in 1992 and operates from its headquarters in San Diego, California.",
"ceo": "Kyle W. Gano",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "2500",
"phone": "858 617 7600",
"address": "6027 Edgewood Bend Court",
"city": "San Diego",
"state": "CA",
"zip": "92130",
"image": "https://images.financialmodelingprep.com/symbol/NBIX.png",
"ipoDate": "1996-05-23",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "NBIX",
"name": "Neurocrine Biosciences, Inc.",
"price": 135.87,
"changePercentage": 0.1179,
"change": 0.16,
"volume": 236635.17063,
"dayLow": 135.005,
"dayHigh": 137.36,
"yearHigh": 186.12,
"yearLow": 122.14,
"marketCap": 13811049630,
"priceAvg50": 149.2596,
"priceAvg200": 147.03865,
"exchange": "NASDAQ",
"open": 136.56,
"previousClose": 135.71,
"timestamp": 1792427205,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-09-08",
"v": 155.5105,
"c": 155.13
},
{
"t": "2026-09-09",
"v": 154.2369,
"c": 155.14
},
{
"t": "2026-09-10",
"v": 157.0805,
"c": 156.57
},
{
"t": "2026-09-11",
"v": 156.7894,
"c": 156.22
},
{
"t": "2026-09-14",
"v": 157.374,
"c": 157.22
},
{
"t": "2026-09-15",
"v": 151.2357,
"c": 150.02
},
{
"t": "2026-09-16",
"v": 150.0884,
"c": 149.5
},
{
"t": "2026-09-17",
"v": 151.3314,
"c": 151.83
},
{
"t": "2026-09-18",
"v": 147.1394,
"c": 146.23
},
{
"t": "2026-09-21",
"v": 144.2424,
"c": 143.96
},
{
"t": "2026-09-22",
"v": 142.7696,
"c": 142.25
},
{
"t": "2026-09-23",
"v": 140.3649,
"c": 139.49
},
{
"t": "2026-09-24",
"v": 138.9968,
"c": 138.94
},
{
"t": "2026-09-25",
"v": 138.0965,
"c": 138.4
},
{
"t": "2026-09-28",
"v": 139.5176,
"c": 140.44
},
{
"t": "2026-09-29",
"v": 137.6747,
"c": 138.35
},
{
"t": "2026-09-30",
"v": 141.2332,
"c": 141.84
},
{
"t": "2026-10-01",
"v": 141.4287,
"c": 140.71
},
{
"t": "2026-10-02",
"v": 143.0064,
"c": 143.18
},
{
"t": "2026-10-05",
"v": 144.858,
"c": 144.21
},
{
"t": "2026-10-06",
"v": 144.6561,
"c": 145.51
},
{
"t": "2026-10-07",
"v": 144.1596,
"c": 143.47
},
{
"t": "2026-10-08",
"v": 141.5862,
"c": 141.25
},
{
"t": "2026-10-09",
"v": 142.2401,
"c": 142.44
},
{
"t": "2026-10-12",
"v": 141.5218,
"c": 141.37
},
{
"t": "2026-10-13",
"v": 135.9867,
"c": 135.13
},
{
"t": "2026-10-14",
"v": 135.5798,
"c": 135.91
},
{
"t": "2026-10-15",
"v": 136.9191,
"c": 136.95
},
{
"t": "2026-10-16",
"v": 136.1497,
"c": 135.71
},
{
"t": "2026-10-19",
"v": 135.871,
"c": 135.8
}
],
"vwap_summary": {
"days": 30,
"days_above": 11,
"days_below": 19,
"pct_days_above": 37,
"position": "below",
"gap_pct": -0.05,
"streak_days": 2
}
}
Data:
{
"volume": 236635.17063,
"avgVolume": 1274767,
"short_ratio": [
{
"symbol": "NBIX",
"file_date": "2026-10-16",
"date": "20261016",
"short_volume": 183900,
"short_exempt_volume": 10,
"total_volume": 287840,
"short_volume_ratio": 0.6389,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 142.32,
"vah": 144.47,
"val": 137.47,
"profile": [
{
"price": 133.28,
"volume": 82404
},
{
"price": 133.51,
"volume": 0
},
{
"price": 133.74,
"volume": 19591
},
{
"price": 133.96,
"volume": 0
},
{
"price": 134.19,
"volume": 0
},
{
"price": 134.41,
"volume": 0
},
{
"price": 134.64,
"volume": 0
},
{
"price": 134.87,
"volume": 18171
},
{
"price": 135.09,
"volume": 177085
},
{
"price": 135.32,
"volume": 333299
},
{
"price": 135.54,
"volume": 246718
},
{
"price": 135.77,
"volume": 492350
},
{
"price": 136.0,
"volume": 546685
},
{
"price": 136.22,
"volume": 322104
},
{
"price": 136.45,
"volume": 287968
},
{
"price": 136.67,
"volume": 400444
},
{
"price": 136.9,
"volume": 584823
},
{
"price": 137.13,
"volume": 417175
},
{
"price": 137.35,
"volume": 396425
},
{
"price": 137.58,
"volume": 242379
},
{
"price": 137.8,
"volume": 556072
},
{
"price": 138.03,
"volume": 478221
},
{
"price": 138.26,
"volume": 553395
},
{
"price": 138.48,
"volume": 169565
},
{
"price": 138.71,
"volume": 165683
},
{
"price": 138.93,
"volume": 429985
},
{
"price": 139.16,
"volume": 336347
},
{
"price": 139.39,
"volume": 244929
},
{
"price": 139.61,
"volume": 263725
},
{
"price": 139.84,
"volume": 297028
},
{
"price": 140.06,
"volume": 463480
},
{
"price": 140.29,
"volume": 614483
},
{
"price": 140.52,
"volume": 492809
},
{
"price": 140.74,
"volume": 694573
},
{
"price": 140.97,
"volume": 543115
},
{
"price": 141.19,
"volume": 491099
},
{
"price": 141.42,
"volume": 648085
},
{
"price": 141.65,
"volume": 459062
},
{
"price": 141.87,
"volume": 341442
},
{
"price": 142.1,
"volume": 722654
},
{
"price": 142.32,
"volume": 868196
},
{
"price": 142.55,
"volume": 458280
},
{
"price": 142.78,
"volume": 520417
},
{
"price": 143.0,
"volume": 531978
},
{
"price": 143.23,
"volume": 743356
},
{
"price": 143.45,
"volume": 552897
},
{
"price": 143.68,
"volume": 189475
},
{
"price": 143.91,
"volume": 181775
},
{
"price": 144.13,
"volume": 308080
},
{
"price": 144.36,
"volume": 363487
},
{
"price": 144.58,
"volume": 87336
},
{
"price": 144.81,
"volume": 265413
},
{
"price": 145.04,
"volume": 201305
},
{
"price": 145.26,
"volume": 111364
},
{
"price": 145.49,
"volume": 384119
},
{
"price": 145.71,
"volume": 83141
},
{
"price": 145.94,
"volume": 42022
},
{
"price": 146.17,
"volume": 75389
},
{
"price": 146.39,
"volume": 122542
},
{
"price": 146.62,
"volume": 121063
}
],
"sessions": 20
}
}
Data:
{
"symbol": "NBIX",
"marketCap": 13816609830,
"enterpriseValueTTM": 13885277957,
"evToSalesTTM": 4.115714701087763,
"evToOperatingCashFlowTTM": 15.461540841777085,
"evToFreeCashFlowTTM": 15.953595852481616,
"evToEBITDATTM": 15.124724790327852,
"netDebtToEBITDATTM": 0.07559089423810042,
"currentRatioTTM": 1.8724985706117783,
"incomeQualityTTM": 1.2729978738483345,
"grahamNumberTTM": 75.812937613945,
"grahamNetNetTTM": -5.528217821782178,
"taxBurdenTTM": 0.7503722612210169,
"interestBurdenTTM": 1.079696830500689,
"workingCapitalTTM": 763000000,
"investedCapitalTTM": 4028100000,
"returnOnAssetsTTM": 0.13164523893937416,
"operatingReturnOnAssetsTTM": 0.15370227855006674,
"returnOnTangibleAssetsTTM": 0.26799620132953467,
"returnOnEquityTTM": 0.21126391519498117,
"returnOnInvestedCapitalTTM": 0.13200032932195965,
"returnOnCapitalEmployedTTM": 0.1759131249163805,
"earningsYieldTTM": 0.05138983948356322,
"freeCashFlowYieldTTM": 0.06299664032707218,
"capexToOperatingCashFlowTTM": 0.03084289054670972,
"capexToDepreciationTTM": 0.5856236786469344,
"capexToRevenueTTM": 0.008210083286404457,
"salesGeneralAndAdministrativeToRevenueTTM": 0.40060464151278935,
"researchAndDevelopementToRevenueTTM": 0.33525000740982247,
"stockBasedCompensationToRevenueTTM": 0.06950413468093304,
"intangiblesToTotalAssetsTTM": 0.5087794592375585,
"averageReceivablesTTM": 827550000,
"averagePayablesTTM": 131000000,
"averageInventoryTTM": 84350000,
"daysOfSalesOutstandingTTM": 95.95868282995939,
"daysOfPayablesOutstandingTTM": 755.539358600583,
"daysOfInventoryOutstandingTTM": 554.4169096209912,
"operatingCycleTTM": 650.3755924509505,
"cashConversionCycleTTM": -105.16376614963247,
"freeCashFlowToEquityTTM": 870400000,
"freeCashFlowToFirmTTM": 872576079.5575409,
"tangibleAssetValueTTM": 967000000,
"netCurrentAssetValueTTM": -28000000,
"grossProfitMarginTTM": 0.9796674471679658,
"ebitMarginTTM": 0.2580989359494946,
"ebitdaMarginTTM": 0.2721183200450517,
"operatingProfitMarginTTM": 0.23382435756839265,
"pretaxProfitMarginTTM": 0.2786686031002697,
"continuousOperationsProfitMarginTTM": 0.20910518983965143,
"netProfitMarginTTM": 0.20910518983965143,
"bottomLineProfitMarginTTM": 0.20910518983965143,
"receivablesTurnoverTTM": 3.8037204058624576,
"payablesTurnoverTTM": 0.4830985915492958,
"inventoryTurnoverTTM": 0.6583493282149712,
"fixedAssetTurnoverTTM": 6.265366759517177,
"assetTurnoverTTM": 0.6295646657087944,
"quickRatioTTM": 1.7533447684391081,
"solvencyRatioTTM": 0.4519963974782348,
"cashRatioTTM": 0.38010291595197254,
"priceToEarningsRatioTTM": 19.279078014184396,
"priceToEarningsGrowthRatioTTM": 0.18793050837356218,
"forwardPriceToEarningsGrowthRatioTTM": 0.4664860745541181,
"priceToEarningsDilutedRatioTTM": 19.92925219941349,
"priceToEarningsDilutedGrowthRatioTTM": 0.19581648963377202,
"priceToBookRatioTTM": 3.7166091347195147,
"priceToSalesRatioTTM": 4.094928111977238,
"priceToFreeCashFlowRatioTTM": 15.87302154986213,
"priceToOperatingCashFlowRatioTTM": 15.28523271350629,
"debtToAssetsRatioTTM": 0.07497527569927787,
"debtToEquityRatioTTM": 0.10878275936755469,
"debtToCapitalRatioTTM": 0.09811007471797627,
"longTermDebtToCapitalRatioTTM": 0,
"financialLeverageRatioTTM": 1.4509150963829327,
"workingCapitalTurnoverRatioTTM": 2.850299907071048,
"operatingCashFlowRatioTTM": 1.026986849628359,
"operatingCashFlowSalesRatioTTM": 0.26619046207652863,
"freeCashFlowOperatingCashFlowRatioTTM": 0.9691571094532903,
"debtServiceCoverageRatioTTM": 235.6551724137931,
"interestCoverageRatioTTM": 272.0344827586207,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": 2.235191637630662,
"capitalExpenditureCoverageRatioTTM": 32.42238267148014,
"dividendPaidAndCapexCoverageRatioTTM": 32.42238267148014,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 33.404950495049505,
"netIncomePerShareTTM": 6.985148514851486,
"interestDebtPerShareTTM": 4.0069306930693065,
"cashPerShareTTM": 3.8594059405940593,
"bookValuePerShareTTM": 36.57029702970297,
"tangibleBookValuePerShareTTM": 9.574257425742575,
"shareholdersEquityPerShareTTM": 36.57029702970297,
"operatingCashFlowPerShareTTM": 8.892079207920792,
"capexPerShareTTM": 0.2742574257425743,
"freeCashFlowPerShareTTM": 8.617821782178218,
"netIncomePerEBTTTM": 0.7503722612210169,
"ebtPerEbitTTM": 1.1917860311826594,
"priceToFairValueTTM": 3.7166091347195147,
"debtToMarketCapTTM": 0,
"effectiveTaxRateTTM": 0.2496277387789832,
"enterpriseValueMultipleTTM": 15.123927629887813,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 2860500000
}
],
"dcf": {
"symbol": "NBIX",
"date": "2026-10-19",
"dcf": 305.41864878173385,
"Stock Price": 135.71
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "NBIX",
"reportedCurrency": "USD",
"cik": "0000914475",
"filingDate": "2026-02-11",
"acceptedDate": "2026-02-11 16:03:36",
"fiscalYear": "2025",
"period": "FY",
"revenue": 2860500000,
"costOfRevenue": 52100000,
"grossProfit": 2808400000,
"researchAndDevelopmentExpenses": 1015700000,
"generalAndAdministrativeExpenses": 0,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 1156200000,
"otherExpenses": 17400000,
"operatingExpenses": 2189300000,
"costAndExpenses": 2241400000,
"netInterestIncome": 90300000,
"interestIncome": 90300000,
"interestExpense": 0,
"depreciationAndAmortization": 30100000,
"ebitda": 666600000,
"ebit": 636500000,
"nonOperatingIncomeExcludingInterest": -17400000,
"operatingIncome": 619100000,
"totalOtherIncomeExpensesNet": 86300000,
"incomeBeforeTax": 705400000,
"incomeTaxExpense": 226800000,
"netIncomeFromContinuingOperations": 478600000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 478600000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 478600000,
"eps": 4.81,
"epsDiluted": 4.67,
"weightedAverageShsOut": 99500000,
"weightedAverageShsOutDil": 102500000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "NBIX",
"reportedCurrency": "USD",
"cik": "0000914475",
"filingDate": "2026-02-11",
"acceptedDate": "2026-02-11 16:03:36",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 713000000,
"shortTermInvestments": 767400000,
"cashAndShortTermInvestments": 1480400000,
"netReceivables": 686800000,
"accountsReceivables": 686800000,
"otherReceivables": 0,
"inventory": 69000000,
"prepaids": 170700000,
"otherCurrentAssets": 115800000,
"totalCurrentAssets": 2522700000,
"propertyPlantEquipmentNet": 545200000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 1183800000,
"taxAssets": 320300000,
"otherNonCurrentAssets": 59500000,
"totalNonCurrentAssets": 2108800000,
"otherAssets": 0,
"totalAssets": 4631500000,
"totalPayables": 172900000,
"accountPayables": 104900000,
"otherPayables": 68000000,
"accruedExpenses": 146600000,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 423900000,
"totalCurrentLiabilities": 743400000,
"longTermDebt": 0,
"capitalLeaseObligationsNonCurrent": 415300000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 219700000,
"totalNonCurrentLiabilities": 635000000,
"otherLiabilities": 0,
"capitalLeaseObligations": 415300000,
"totalLiabilities": 1378400000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 100000,
"retainedEarnings": 447700000,
"additionalPaidInCapital": 2792200000,
"accumulatedOtherComprehensiveIncomeLoss": 13100000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 3253100000,
"totalEquity": 3253100000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 4631500000,
"totalInvestments": 1951200000,
"totalDebt": 415300000,
"netDebt": -297700000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "NBIX",
"reportedCurrency": "USD",
"cik": "0000914475",
"filingDate": "2026-02-11",
"acceptedDate": "2026-02-11 16:03:36",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 478600000,
"depreciationAndAmortization": 30100000,
"deferredIncomeTax": 165400000,
"stockBasedCompensation": 217900000,
"changeInWorkingCapital": -128800000,
"accountsReceivables": -210500000,
"inventory": -15300000,
"accountsPayables": 0,
"otherWorkingCapital": 97000000,
"otherNonCashItems": 19500000,
"netCashProvidedByOperatingActivities": 782700000,
"investmentsInPropertyPlantAndEquipment": -34000000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -1319800000,
"salesMaturitiesOfInvestments": 1089400000,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": -264399999,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": -38300000,
"netCommonStockIssuance": -38300000,
"commonStockIssuance": 129400000,
"commonStockRepurchased": -167700000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": -38300000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": 480000000,
"cashAtEndOfPeriod": 721000000,
"cashAtBeginningOfPeriod": 241000000,
"operatingCashFlow": 782700000,
"capitalExpenditure": -34000000,
"freeCashFlow": 748700000,
"incomeTaxesPaid": 81400000,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 135.9,
"rsi": 35.045890465427476,
"sma20": 140.07250000000005,
"sma50": 148.70940000000004,
"sma200": 147.00899999999993,
"adx": 28.84635899472936,
"atr": 3.78,
"atr_pct": 2.78,
"atr_expansion_pct": 2.2,
"di_plus": 15.5,
"di_minus": 24.8,
"high_52w": 185.5,
"low_52w": 123.1,
"structure": {
"ema8": 137.79293098312897,
"ema21": 141.3786257062433,
"ema50": 147.73945748799727,
"ema200": 148.73397478486308,
"ema10": 138.3847118233111,
"ema20": 141.1109023894539,
"ema10_slope_pct": -2.94,
"ema20_slope_pct": -2.32,
"trend_dir": "down",
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": false,
"adx_over_30": false,
"higher_highs_lows": false,
"lower_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": -3.9,
"_no_bars": false,
"macd": {
"macd": -3.763,
"signal": -3.668,
"histogram": -0.095
},
"bollinger": {
"mid": 140.07,
"upper": 146.08,
"lower": 134.07,
"width_pct": 8.57
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": -5.8,
"ret_3d": -0.01,
"ret_5d": -3.87,
"roc10_accel": -6.42,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.17,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 6.34,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 173279078.31
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.1,
"iv_rank": 52.0
}
}
}
}
Data:
{
"prior_day": {
"high": 137.53,
"low": 135.0,
"close": 135.8,
"date": "2026-10-19"
},
"woodie_pivots": {
"PP": 136.03,
"R1": 137.06,
"S1": 134.54,
"R2": 138.56,
"S2": 133.51
},
"swing": {
"high_20d": 146.91,
"low_20d": 132.25,
"high_60d": 186.12,
"low_60d": 132.25
},
"orb": {
"high": 137.53,
"low": 136,
"date": "2026-10-19"
},
"vwap": 135.87,
"volume_profile": {
"poc": 142.32,
"vah": 144.47,
"val": 137.47,
"sessions": 20
},
"intraday": {
"h1_trend": "down",
"h1_last": 135.82,
"h1_ema9": 136.08,
"h1_ema21": 136.57,
"m15_trend": "flat",
"m15_last": 135.98,
"m15_ema9": 135.84,
"m15_ema21": 135.95,
"rvol_intraday": 0.6,
"as_of_et": "2026-10-19 12:25"
},
"premarket": {
"date": "2026-10-19",
"high": 136.3,
"low": 134.5,
"last": 136.25,
"volume": 4985,
"gap_pct": 0.4,
"path": "08:35 136.21 -> 08:40 136.20 -> 08:45 136.25",
"bars": 3,
"last_bar_et": "08:45"
},
"recent_daily": [
{
"d": "2026-09-15",
"o": 156.7,
"h": 156.7,
"l": 149.15,
"c": 150.02,
"v": 1332180.027398
},
{
"d": "2026-09-16",
"o": 150.34,
"h": 151.31,
"l": 149,
"c": 149.5,
"v": 1015821.95373
},
{
"d": "2026-09-17",
"o": 151.14,
"h": 152.065,
"l": 149.71,
"c": 151.83,
"v": 1178348.479098
},
{
"d": "2026-09-18",
"o": 152.63,
"h": 152.63,
"l": 146.06,
"c": 146.23,
"v": 2816257.963451
},
{
"d": "2026-09-21",
"o": 146.15,
"h": 146.26,
"l": 143.45,
"c": 143.96,
"v": 1385320.551824
},
{
"d": "2026-09-22",
"o": 144.17,
"h": 144.26,
"l": 141.78,
"c": 142.25,
"v": 1213787.737511
},
{
"d": "2026-09-23",
"o": 141.97,
"h": 142.245,
"l": 139.3167,
"c": 139.49,
"v": 1747918.235454
},
{
"d": "2026-09-24",
"o": 138.54,
"h": 140.63,
"l": 137,
"c": 138.94,
"v": 1169298.734357
},
{
"d": "2026-09-25",
"o": 138.94,
"h": 138.94,
"l": 137.02,
"c": 138.4,
"v": 1171038.641017
},
{
"d": "2026-09-28",
"o": 137.76,
"h": 140.59,
"l": 136.78,
"c": 140.44,
"v": 1431627.194277
},
{
"d": "2026-09-29",
"o": 138.26,
"h": 141.07,
"l": 136.31,
"c": 138.35,
"v": 1499018.971132
},
{
"d": "2026-09-30",
"o": 138.33,
"h": 142.91,
"l": 137.63,
"c": 141.84,
"v": 1847008.5633
},
{
"d": "2026-10-01",
"o": 140.94,
"h": 143.74,
"l": 139.61,
"c": 140.71,
"v": 2051997.069522
},
{
"d": "2026-10-02",
"o": 141.41,
"h": 144.56,
"l": 140.36,
"c": 143.18,
"v": 1648262.455202
},
{
"d": "2026-10-05",
"o": 142.94,
"h": 146.915,
"l": 142.48,
"c": 144.21,
"v": 1748233.755567
},
{
"d": "2026-10-06",
"o": 145.56,
"h": 145.77,
"l": 141.39,
"c": 145.51,
"v": 1449570.99396
},
{
"d": "2026-10-07",
"o": 145.33,
"h": 145.88,
"l": 143.21,
"c": 143.47,
"v": 1143737.593562
},
{
"d": "2026-10-08",
"o": 142.88,
"h": 143.02,
"l": 140.34,
"c": 141.25,
"v": 1237201.602202
},
{
"d": "2026-10-09",
"o": 141.33,
"h": 143.55,
"l": 140.02,
"c": 142.44,
"v": 1019550.04547
},
{
"d": "2026-10-12",
"o": 142.37,
"h": 143.625,
"l": 140.89,
"c": 141.37,
"v": 1092123.563006
},
{
"d": "2026-10-13",
"o": 139.6,
"h": 139.925,
"l": 134.89,
"c": 135.13,
"v": 1568446.024918
},
{
"d": "2026-10-14",
"o": 133.94,
"h": 136.5699,
"l": 132.25,
"c": 135.91,
"v": 1506704.430589
},
{
"d": "2026-10-15",
"o": 137.26,
"h": 138.23,
"l": 135.55,
"c": 136.95,
"v": 1379144.208376
},
{
"d": "2026-10-16",
"o": 137.86,
"h": 138.1994,
"l": 135.55,
"c": 135.71,
"v": 1127483.453247
},
{
"d": "2026-10-19",
"o": 136.335,
"h": 137.53,
"l": 135.005,
"c": 135.8,
"v": 236065.119924
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 2.02,
"etf_rvol": 0.43,
"rs_5d": -6.75,
"leading": false
}
Data:
{
"estimates": [
{
"symbol": "NBIX",
"date": "2030-12-31",
"revenueLow": 5358187310,
"revenueHigh": 6006400782,
"revenueAvg": 5630893783,
"ebitdaLow": 1910944053,
"ebitdaHigh": 2199460109,
"ebitdaAvg": 2032324642,
"ebitLow": 1850256610,
"ebitHigh": 2138772666,
"ebitAvg": 1971637199,
"netIncomeLow": 1350757313,
"netIncomeHigh": 1566483940,
"netIncomeAvg": 1441514914,
"sgaExpenseLow": 2488757358,
"sgaExpenseHigh": 2789837920,
"sgaExpenseAvg": 2615423374,
"epsAvg": 14.06356,
"epsHigh": 15.28277,
"epsLow": 13.17812,
"numAnalystsRevenue": 15,
"numAnalystsEps": 7
},
{
"symbol": "NBIX",
"date": "2029-12-31",
"revenueLow": 5005321566,
"revenueHigh": 5610846659,
"revenueAvg": 5260068836,
"ebitdaLow": 1767151652,
"ebitdaHigh": 2033644995,
"ebitdaAvg": 1879266662,
"ebitLow": 1712360013,
"ebitHigh": 1978853356,
"ebitAvg": 1824475023,
"netIncomeLow": 1247650512,
"netIncomeHigh": 1446910514,
"netIncomeAvg": 1331480137,
"sgaExpenseLow": 2324859165,
"sgaExpenseHigh": 2606111936,
"sgaExpenseAvg": 2443183536,
"epsAvg": 12.99005,
"epsHigh": 14.1162,
"epsLow": 12.1722,
"numAnalystsRevenue": 9,
"numAnalystsEps": 12
},
{
"symbol": "NBIX",
"date": "2028-12-31",
"revenueLow": 4704107848,
"revenueHigh": 5320718658,
"revenueAvg": 5044314729,
"ebitdaLow": 1363718623,
"ebitdaHigh": 2414242508,
"ebitdaAvg": 2238886151,
"ebitLow": 1314909319,
"ebitHigh": 2365433204,
"ebitAvg": 2190076847,
"netIncomeLow": 950472259,
"netIncomeHigh": 1735960516,
"netIncomeAvg": 1604844640,
"sgaExpenseLow": 2184952175,
"sgaExpenseHigh": 2471354012,
"sgaExpenseAvg": 2342970611,
"epsAvg": 12.37945,
"epsHigh": 16.9362,
"epsLow": 9.2729,
"numAnalystsRevenue": 19,
"numAnalystsEps": 17
},
{
"symbol": "NBIX",
"date": "2027-12-31",
"revenueLow": 4116649605,
"revenueHigh": 5044913732,
"revenueAvg": 4520242704,
"ebitdaLow": 1042674895,
"ebitdaHigh": 1921745135,
"ebitdaAvg": 1760363406,
"ebitLow": 1000536279,
"ebitHigh": 1879606519,
"ebitAvg": 1718224790,
"netIncomeLow": 715412081,
"netIncomeHigh": 1372702563,
"netIncomeAvg": 1252035670,
"sgaExpenseLow": 1912091049,
"sgaExpenseHigh": 2343248834,
"sgaExpenseAvg": 2099550956,
"epsAvg": 9.72312,
"epsHigh": 13.39222,
"epsLow": 6.97963,
"numAnalystsRevenue": 18,
"numAnalystsEps": 15
}
],
"price_target": {
"symbol": "NBIX",
"targetHigh": 230,
"targetLow": 165,
"targetConsensus": 204.18,
"targetMedian": 210
},
"ratings": {
"symbol": "NBIX",
"rating": "A",
"overallScore": 4,
"discountedCashFlowScore": 5,
"returnOnEquityScore": 5,
"returnOnAssetsScore": 5,
"debtToEquityScore": 3,
"priceToEarningsScore": 2,
"priceToBookScore": 2
},
"grades": [
{
"symbol": "NBIX",
"date": "2026-10-16",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-10-12",
"gradingCompany": "BMO Capital",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-09-29",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-09-11",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-09-08",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-09-03",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-08-13",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-08-03",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-08-03",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-08-03",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-31",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-31",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-31",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-31",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-31",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-31",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-31",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-31",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-31",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-21",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-17",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-13",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-13",
"gradingCompany": "BMO Capital",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-06-30",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-05-29",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-05-08",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-05-07",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-05-06",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-05-06",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-05-06",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-05-06",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-05-06",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-05-06",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-04-22",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-04-10",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-04-07",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-04-07",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-04-07",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-04-07",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-04-06",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-03-12",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-02-17",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-02-17",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-02-13",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-02-12",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-02-12",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-02-12",
"gradingCompany": "BMO Capital",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-02-12",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-02-12",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-02-12",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-01-23",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-01-12",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-01-08",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2026-01-08",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Equal Weight",
"action": "downgrade"
},
{
"symbol": "NBIX",
"date": "2025-12-17",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-12-12",
"gradingCompany": "Mizuho",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-12-11",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-12-08",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-12-05",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-11-11",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-11-03",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-10-30",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-10-29",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-10-29",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-10-29",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-10-29",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-10-29",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-10-29",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "NBIX",
"date": "2025-10-20",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia",
"url": "https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-real-world-evidence-mapping-the-lifelong-evolving-impact-of-classic-congenital-adrenal-hyperplasia-302910704.html",
"source": "PRNewsWire",
"date": "2026-10-16 08:30:00",
"summary": "Decades of real-world medical records highlight the diverse challenges of living with classic congenital adrenal hyperplasia and how needs evolve from childhood through adulthood Patient records showed growth and bone-age monitoring in childhood; puberty and reproductive health c",
"image": "https://images.financialmodelingprep.com/news/neurocrine-biosciences-presents-realworld-evidence-mapping-the-lifelong-evolving-20261016.jpg"
},
{
"title": "Obesity Clinical Trial and Competitive Landscape Surges as 200+ Companies Advance Next-Generation Therapies | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2026/10/15/3382029/0/en/obesity-clinical-trial-and-competitive-landscape-surges-as-200-companies-advance-next-generation-therapies-delveinsight.html",
"source": "GlobeNewswire Inc.",
"date": "2026-10-15T17:00:00Z",
"summary": "Over 200 companies are advancing next-generation obesity therapies, with more than 30 drugs in late-stage development and 180+ in mid and early stages. Key players include Eli Lilly, Novo Nordisk, Viking Therapeutics, and Roche, developing innovative mechanisms like dual GLP-1/GI",
"image": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db"
},
{
"title": "Why Neurocrine Biosciences (NBIX) is a Top Value Stock for the Long-Term",
"url": "https://www.zacks.com/stock/news/3006886/why-neurocrine-biosciences-nbix-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-fundamental_analysis|zacks_education_value_score-3006886",
"source": "Zacks Investment Research",
"date": "2026-10-14T12:40:03Z",
"summary": "Neurocrine Biosciences (NBIX), a neuroscience-focused biopharmaceutical company, has been identified as a top value stock with a Zacks Rank #2 (Buy) rating and a VGM Score of A. The company features an attractive forward P/E ratio of 14.86, a Value Style Score of B, and has seen ",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default1.jpg"
},
{
"title": "NBIX vs. SDZNY: Which Stock Should Value Investors Buy Now?",
"url": "https://www.zacks.com/stock/news/3006215/nbix-vs-sdzny-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-fundamental_analysis|yseop_template_3-3006215",
"source": "Zacks Investment Research",
"date": "2026-10-13T14:40:01Z",
"summary": "A comparison of two Medical-Drugs sector stocks reveals that Neurocrine Biosciences (NBIX) presents a better value opportunity than Sandoz Group AG (SDZNY). Both stocks hold a Zacks Rank #2 (Buy) with positive earnings outlooks, but NBIX's superior valuation metrics\u2014including a l",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default361.jpg"
},
{
"title": "Why Neurocrine Biosciences (NBIX) is a Top Growth Stock for the Long-Term",
"url": "https://www.zacks.com/stock/news/3005965/why-neurocrine-biosciences-nbix-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-fundamental_analysis|zacks_education_growth_score-3005965",
"source": "Zacks Investment Research",
"date": "2026-10-13T12:45:12Z",
"summary": "Neurocrine Biosciences (NBIX), a neuroscience-focused biopharmaceutical company, has been identified as a top growth stock with a Zacks Rank #2 (Buy) rating and a VGM Score of A. The company is forecasting year-over-year earnings growth of 42.3% for fiscal 2026, with a consensus ",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default126.jpg"
},
{
"title": "Head-To-Head Contrast: Neurocrine Biosciences (NASDAQ:NBIX) vs. Amneal Pharmaceuticals (NASDAQ:AMRX)",
"url": "https://www.defenseworld.net/2026/10/13/head-to-head-contrast-neurocrine-biosciences-nasdaqnbix-vs-amneal-pharmaceuticals-nasdaqamrx.html",
"source": "Defense World",
"date": "2026-10-13 03:29:03",
"summary": "Amneal Pharmaceuticals (NASDAQ: AMRX - Get Free Report) and Neurocrine Biosciences (NASDAQ: NBIX - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst rec",
"image": "https://images.financialmodelingprep.com/news/headtohead-contrast-neurocrine-biosciences-nasdaqnbix-vs-amneal-pharmaceuticals-nasdaqamrx-20261013.png"
},
{
"title": "Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results",
"url": "https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-conference-call-and-webcast-of-third-quarter-2026-financial-results-302906096.html",
"source": "PRNewsWire",
"date": "2026-10-12 16:01:00",
"summary": "Conference Call and Webcast Scheduled for Monday, November 2 SAN DIEGO, Oct. 12, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its third quarter 2026 financial results conference call and webcast for 1:30 p.m. Pacific Time ",
"image": "https://images.financialmodelingprep.com/news/neurocrine-biosciences-announces-conference-call-and-webcast-of-third-20261012.jpg"
},
{
"title": "4 CNS Drug Stocks Worth Watching This World Mental Health Day",
"url": "https://www.zacks.com/stock/news/3003805/4-cns-drug-stocks-worth-watching-this-world-mental-health-day?cid=CS-ZC-FT-analyst_blog|investment_ideas-3003805",
"source": "Zacks Investment Research",
"date": "2026-10-09T13:28:00Z",
"summary": "Four central nervous system (CNS) pharmaceutical companies\u2014Axsome Therapeutics, Neurocrine Biosciences, Alkermes, and Acadia Pharmaceuticals\u2014are highlighted as relevant investment opportunities ahead of World Mental Health Day. All four companies carry a Zacks Rank #3 (Hold) rati",
"image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg"
},
{
"title": "Here Are Tuesday\u2019s Top Wall Street Analyst Research Calls: Borg Warner, Boyd Gaming, JetBlue, Lattice Semiconductor, Lockheed Martin, Nike, Northrop Grumman, Procter & Gamble, SPX Technologies, and More",
"url": "https://247wallst.com/investing/2026/10/06/here-are-tuesdays-top-wall-street-analyst-research-calls-borg-warner-boyd-gaming-jetblue-lattice-semiconductor-lockheed-martin-nike-northrop-grumman-procter-gamble-spx-technologies/",
"source": "247 Wallst",
"date": "2026-10-06 07:54:14",
"summary": "Pre-Market Stock Futures: Futures are trading higher after we started off the first full trading week of the undefined quarter in solid style, as all major indices finished the day higher despite interest rates continuing to tick higher. Technology led the way, and the tech-heavy",
"image": "https://images.financialmodelingprep.com/news/here-are-tuesdays-top-wall-street-analyst-research-calls-20261006.jpg"
},
{
"title": "Neurocrine to present Prader-Willi syndrome research at FPWR event By Investing.com",
"url": "https://www.investing.com/news/company-news/neurocrine-to-present-praderwilli-syndrome-research-at-fpwr-event-93CH-4925162",
"source": "Investing.com",
"date": "2026-09-30T12:44:33Z",
"summary": "SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ:NBIX) announced today it will present research on Prader-Willi syndrome and VYKAT XR at the Foundation for Prader-Willi Research 2026 Annual Research Symposium & Family Conference, scheduled for Oct. 7-10 in Philadelphia.\n\nThe pres",
"image": "https://content-media.investing.com/news/LYNXMPEM18116_1200_L.jpg"
},
{
"title": "Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT\u00ae XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference",
"url": "https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-research-advancing-understanding-of-prader-willi-syndrome-and-real-world-experience-with-vykat-xr-diazoxide-choline-at-foundation-for-prader-willi-research-symposium--family-conference-302893567.html",
"source": "PRNewsWire",
"date": "2026-09-30 08:30:00",
"summary": "PWS-VISTA observational study will build longitudinal real-world evidence on VYKAT XR use for hyperphagia in Prader-Willi syndrome in routine clinical practice BRAVE-PWS observational study will capture caregiver-reported information to better understand the experience and burden",
"image": "https://images.financialmodelingprep.com/news/neurocrine-biosciences-to-present-research-advancing-understanding-of-praderwilli-20260930.jpg"
},
{
"title": "UBS cuts Neurocrine Biosciences stock price target to $214 on competition By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/ubs-cuts-neurocrine-biosciences-stock-price-target-to-214-on-competition-93CH-4922947",
"source": "Investing.com",
"date": "2026-09-29T14:00:56Z",
"summary": "Investing.com - UBS lowered its price target on Neurocrine Biosciences Inc. (NASDAQ:NBIX) to $214 from $231 while maintaining a Buy rating on the stock.\n\nThe firm cited the stock's 25% decline since the second-quarter earnings report, driven by negative developments including add",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3Q0V4_1200_L.jpg"
},
{
"title": "Neurocrine Biosciences Appoints Eiry W. Roberts, M.D.",
"url": "https://www.prnewswire.com/news-releases/neurocrine-biosciences-appoints-eiry-w-roberts-md-as-chief-medical-officer-302891904.html",
"source": "PRNewsWire",
"date": "2026-09-28 16:05:00",
"summary": "SAN DIEGO, Sept. 28, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Eiry W.",
"image": "https://images.financialmodelingprep.com/news/neurocrine-biosciences-appoints-eiry-w-roberts-md-20260928.jpg"
},
{
"title": "Neurocrine Maps AI, China and Pipeline Strategy as INGREZZA Faces 2029 Price Hit",
"url": "https://www.marketbeat.com/instant-alerts/event-neurocrine-maps-ai-china-and-pipeline-strategy-as-ingrezza-faces-2029-price-hit-2026-09-22/",
"source": "MarketBeat",
"date": "2026-09-23 00:02:42",
"summary": "Neurocrine Biosciences NASDAQ: NBIX outlined its commercial growth priorities, pricing considerations and pipeline plans during a Morgan Stanley discussion, with CEO Kyle Gano emphasizing the company's efforts to diversify beyond its largest product, INGREZZA.",
"image": "https://images.financialmodelingprep.com/news/neurocrine-maps-ai-china-and-pipeline-strategy-as-ingrezza-20260923.jpg"
},
{
"title": "Neurocrine's (NBIX) Data Deluge Reshapes A Familiar Growth Story",
"url": "https://finance.yahoo.com/healthcare/articles/neurocrine-nbix-data-deluge-reshapes-044725231.html",
"source": "Yahoo! Finance",
"date": "2026-09-18T04:47:25Z",
"summary": "On August 12, Neurocrine Biosciences (NASDAQ:NBIX) published something unusual for a psychiatric drug: proof that patients feel the difference, not just that a clinician's scale says they moved less. The KINECT-PRO findings showed INGREZZA easing the daily burden of tardive dyski",
"image": "https://s.yimg.com/lo/mysterio/api/2c540d8f118d8a9e5bab651b007090eb0047955a2f9552ccdbf63f020f63788d/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F0fd268bfdf023d0589a2a4957f4d60fd.jpg"
},
{
"title": "Integrated Wealth Concepts LLC Sells 5,703 Shares of Neurocrine Biosciences, Inc. $NBIX",
"url": "https://www.defenseworld.net/2026/09/17/integrated-wealth-concepts-llc-sells-5703-shares-of-neurocrine-biosciences-inc-nbix.html",
"source": "Defense World",
"date": "2026-09-17 04:24:45",
"summary": "Integrated Wealth Concepts LLC lowered its position in Neurocrine Biosciences, Inc. (NASDAQ: NBIX) by 41.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 8,041 shares of the company's stoc",
"image": "https://images.financialmodelingprep.com/news/integrated-wealth-concepts-llc-sells-5703-shares-of-neurocrine-20260917.jpg"
},
{
"title": "Corient Private Wealth LP Buys 9,645 Shares of Neurocrine Biosciences, Inc. $NBIX",
"url": "https://www.defenseworld.net/2026/09/17/corient-private-wealth-lp-buys-9645-shares-of-neurocrine-biosciences-inc-nbix.html",
"source": "Defense World",
"date": "2026-09-17 03:32:41",
"summary": "Corient Private Wealth LP increased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ: NBIX) by 21.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 54,680 shares of the com",
"image": "https://images.financialmodelingprep.com/news/corient-private-wealth-lp-buys-9645-shares-of-neurocrine-20260917.jpg"
},
{
"title": "Neurocrine Biosciences, Inc. (NBIX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4946574-neurocrine-biosciences-inc-nbix-presents-at-morgan-stanley-24th-annual-global-healthcare",
"source": "Seeking Alpha",
"date": "2026-09-15 20:01:38",
"summary": "Neurocrine Biosciences, Inc. (NBIX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/neurocrine-biosciences-inc-nbix-presents-at-morgan-stanley-24th-20260915.jpg"
},
{
"title": "Engineers Gate Manager LP Increases Holdings in Neurocrine Biosciences, Inc. $NBIX",
"url": "https://www.defenseworld.net/2026/09/14/engineers-gate-manager-lp-increases-holdings-in-neurocrine-biosciences-inc-nbix.html",
"source": "Defense World",
"date": "2026-09-14 04:25:21",
"summary": "Engineers Gate Manager LP raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ: NBIX) by 64.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,361 shares of the company's stock af",
"image": "https://images.financialmodelingprep.com/news/engineers-gate-manager-lp-increases-holdings-in-neurocrine-biosciences-20260914.jpg"
},
{
"title": "Nxera Pharma\u2019s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition",
"url": "https://www.globenewswire.com/news-release/2026/08/26/3351102/0/en/nxera-pharma-s-partner-neurocrine-biosciences-receives-ind-acceptance-from-the-fda-for-phase-2-study-of-nbi-1117567-for-alzheimer-s-cognition.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-26T07:33:00Z",
"summary": "Neurocrine Biosciences has received FDA IND acceptance for a Phase 2 study of NBI-1117567, an oral muscarinic M1/M4 selective agonist for Alzheimer's cognition. Nxera Pharma will receive a $10 million milestone payment. This marks the third compound in Nxera's muscarinic agonist ",
"image": "https://ml-eu.globenewswire.com/Resource/Download/5cc74d52-c86f-4e21-8684-3496281fee15"
},
{
"title": "Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026",
"url": "https://www.globenewswire.com/news-release/2026/08/07/3340927/0/en/nxera-pharma-operational-highlights-and-consolidated-results-for-the-second-quarter-2026.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-07T06:30:00Z",
"summary": "Nxera Pharma reported strong Q2 2026 results with revenue of JPY 18.9 billion, up from the prior year, driven by eight R&D milestone events. The company achieved key regulatory designations for vamorolone in South Korea, progressed partnered programs with Neurocrine, Lilly, and A",
"image": "https://ml-eu.globenewswire.com/Resource/Download/5cc74d52-c86f-4e21-8684-3496281fee15"
},
{
"title": "Tom Lee's Small-Cap Granny Shots ETF Reloads: First Solar, Zoom Among 10 New Buys",
"url": "https://www.benzinga.com/etfs/broad-u-s-equity-etfs/26/06/53130702/tom-lees-small-cap-granny-shots-etf-reloads-first-solar-zoom-among-10-new-buys?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-06-10T20:44:23Z",
"summary": "Fundstrat Capital completed its May 2026 quarterly rebalance of the Fundstrat Granny Shots US Small- & Mid-Cap ETF (GRNJ), adding 10 stocks including First Solar, Zoom, Credo Technology, and Neurocrine Biosciences, while removing 8 positions. CIO Tom Lee positions the portfolio f",
"image": "https://cdn.benzinga.com/cdn-cgi/image/width=1200,height=800,fit=crop/files/images/story/2026/06/10/tom-lee-dall-e_0.png"
},
{
"title": "Nxera Pharma\u2019s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia",
"url": "https://www.globenewswire.com/news-release/2026/04/12/3272170/0/en/Nxera-Pharma-s-Partner-Neurocrine-Biosciences-Doses-First-Patient-in-Phase-2-Trial-of-NBI-1117570-for-Adults-with-Schizophrenia.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-12T23:30:00Z",
"summary": "Neurocrine Biosciences has initiated a Phase 2 clinical trial of NBI-1117570, a dual muscarinic M1/M4 receptor agonist discovered by Nxera Pharma, for treating schizophrenia. Nxera will receive $22.5 million in milestone payments from Neurocrine as a result of this achievement.",
"image": "https://ml-eu.globenewswire.com/Resource/Download/5cc74d52-c86f-4e21-8684-3496281fee15"
},
{
"title": "Why Soleno Therapeutics Stock Rocketed Higher on Monday",
"url": "https://www.fool.com/investing/2026/04/06/why-soleno-therapeutics-stock-rocketed-higher-on-m/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-04-06T20:20:38Z",
"summary": "Soleno Therapeutics agreed to be acquired by peer Neurocrine Biosciences for $2.9 billion, or $53 per share in an all-cash deal, representing a 34% premium. The acquisition is driven by Soleno's FDA-approved drug Vykat XR for treating hyperphagia in Prader-Willi Syndrome patients",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F864202%2Fperson-in-a-lab-gazing-into-a-microscope.jpg&w=1200&op=resize"
},
{
"title": "Neurocrine Buys Soleno To Tap High-Growth Rare Disease Market",
"url": "https://www.benzinga.com/m-a/26/04/51655234/neurocrine-buys-soleno-to-tap-high-growth-rare-disease-market?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-04-06T12:13:38Z",
"summary": "Neurocrine Biosciences announced its acquisition of Soleno Therapeutics for $2.9 billion ($53 per share in cash) to expand its rare disease portfolio with Vykat XR, an FDA-approved treatment for hyperphagia in Prader-Willi syndrome. The deal is expected to close within 90 days. V",
"image": "https://cdn.benzinga.com/files/images/story/2026/04/06/MA.jpeg?width=1200&height=800&fit=crop"
}
]
Data:
[
{
"symbol": "NBIX",
"date": "2026-11-02",
"epsActual": null,
"epsEstimated": 1.93,
"revenueActual": null,
"revenueEstimated": 1044790000,
"lastUpdated": "2026-10-19"
},
{
"symbol": "NBIX",
"date": "2026-07-30",
"epsActual": 2.85,
"epsEstimated": 1.85,
"revenueActual": 959000000,
"revenueEstimated": 890334900,
"lastUpdated": "2026-10-19"
},
{
"symbol": "NBIX",
"date": "2026-05-05",
"epsActual": 1.91,
"epsEstimated": 1.22,
"revenueActual": 814500000,
"revenueEstimated": 768250700,
"lastUpdated": "2026-10-08"
},
{
"symbol": "NBIX",
"date": "2026-02-11",
"epsActual": 1.88,
"epsEstimated": 1.8,
"revenueActual": 805500000,
"revenueEstimated": 790498900,
"lastUpdated": "2026-05-11"
},
{
"symbol": "NBIX",
"date": "2025-10-28",
"epsActual": 2.04,
"epsEstimated": 1.58,
"revenueActual": 794900000,
"revenueEstimated": 806801580,
"lastUpdated": "2026-01-28"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "NBIX",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "NBIX",
"periods": [
{
"file_period": "202607a",
"settlement_date": "20260709",
"quantity_fails": 382,
"price": 178.24
},
{
"file_period": "202607b",
"settlement_date": "20260729",
"quantity_fails": 33,
"price": 182.83
},
{
"file_period": "202608a",
"settlement_date": "20260812",
"quantity_fails": 20,
"price": 161.94
},
{
"file_period": "202608b",
"settlement_date": "20260828",
"quantity_fails": 1609,
"price": 155.92
},
{
"file_period": "202609a",
"settlement_date": "20260911",
"quantity_fails": 1221,
"price": 156.57
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "NBIX",
"filingDate": "2026-10-07",
"transactionDate": "2026-09-28",
"reportingCik": "0001727606",
"companyCik": "0000914475",
"transactionType": "",
"securitiesOwned": 51331,
"reportingName": "ROBERTS EIRY",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 0,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/914475/000172760626000004/0001727606-26-000004-index.htm"
},
{
"symbol": "NBIX",
"filingDate": "2026-10-07",
"transactionDate": "2026-09-28",
"reportingCik": "0001727606",
"companyCik": "0000914475",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "ROBERTS EIRY",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 17147,
"price": 102.9,
"securityName": "Non-Qualified Stock Option",
"url": "https://www.sec.gov/Archives/edgar/data/914475/000172760626000004/0001727606-26-000004-index.htm"
},
{
"symbol": "NBIX",
"filingDate": "2026-10-07",
"transactionDate": "2026-09-28",
"reportingCik": "0001727606",
"companyCik": "0000914475",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "ROBERTS EIRY",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 48199,
"price": 117.63,
"securityName": "Non-Qualified Stock Option",
"url": "https://www.sec.gov/Archives/edgar/data/914475/000172760626000004/0001727606-26-000004-index.htm"
},
{
"symbol": "NBIX",
"filingDate": "2026-10-07",
"transactionDate": "2026-09-28",
"reportingCik": "0001727606",
"companyCik": "0000914475",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "ROBERTS EIRY",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 60005,
"price": 79.02,
"securityName": "Non-Qualified Stock Option",
"url": "https://www.sec.gov/Archives/edgar/data/914475/000172760626000004/0001727606-26-000004-index.htm"
},
{
"symbol": "NBIX",
"filingDate": "2026-10-07",
"transactionDate": "2026-09-28",
"reportingCik": "0001727606",
"companyCik": "0000914475",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "ROBERTS EIRY",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 965,
"price": 103.52,
"securityName": "Incentive Stock Option",
"url": "https://www.sec.gov/Archives/edgar/data/914475/000172760626000004/0001727606-26-000004-index.htm"
},
{
"symbol": "NBIX",
"filingDate": "2026-10-07",
"transactionDate": "2026-09-28",
"reportingCik": "0001727606",
"companyCik": "0000914475",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "ROBERTS EIRY",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 51567,
"price": 103.52,
"securityName": "Non-Qualified Stock Option",
"url": "https://www.sec.gov/Archives/edgar/data/914475/000172760626000004/0001727606-26-000004-index.htm"
},
{
"symbol": "NBIX",
"filingDate": "2026-10-07",
"transactionDate": "2026-09-28",
"reportingCik": "0001727606",
"companyCik": "0000914475",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "ROBERTS EIRY",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 747,
"price": 133.84,
"securityName": "Incentive Stock Option",
"url": "https://www.sec.gov/Archives/edgar/data/914475/000172760626000004/0001727606-26-000004-index.htm"
},
{
"symbol": "NBIX",
"filingDate": "2026-10-07",
"transactionDate": "2026-09-28",
"reportingCik": "0001727606",
"companyCik": "0000914475",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "ROBERTS EIRY",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 21782,
"price": 133.84,
"securityName": "Non-Qualified Stock Option",
"url": "https://www.sec.gov/Archives/edgar/data/914475/000172760626000004/0001727606-26-000004-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "NBIX",
"senateID": "M001136",
"disclosureDate": "2025-08-13",
"transactionDate": "2025-06-17",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030891.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001136",
"disclosureDate": "2025-08-13",
"transactionDate": "2025-06-11",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030891.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2024-12-18",
"transactionDate": "2024-11-19",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220706.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2024-09-18",
"transactionDate": "2024-08-26",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220643.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2023-11-17",
"transactionDate": "2023-10-27",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8220046.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2023-11-17",
"transactionDate": "2023-10-27",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$50,001 - $100,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8220046.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2023-09-20",
"transactionDate": "2023-08-14",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219971.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2023-09-20",
"transactionDate": "2023-08-14",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$50,001 - $100,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219971.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2023-06-22",
"transactionDate": "2023-05-02",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219799.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2023-06-22",
"transactionDate": "2023-05-02",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219799.pdf"
},
{
"symbol": "NBIX",
"senateID": "K000389",
"disclosureDate": "2023-03-08",
"transactionDate": "2023-02-10",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219417.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2023-01-20",
"transactionDate": "2022-12-16",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8219340.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2023-01-20",
"transactionDate": "2022-12-16",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8219340.pdf"
},
{
"symbol": "NBIX",
"senateID": "K000389",
"disclosureDate": "2023-01-03",
"transactionDate": "2022-12-06",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8219318.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2022-02-23",
"transactionDate": "2022-01-28",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8218579.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2022-02-23",
"transactionDate": "2022-01-28",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8218579.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2022-01-27",
"transactionDate": "2021-12-21",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8218545.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2022-01-27",
"transactionDate": "2021-12-14",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Spouse",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8218545.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2021-04-19",
"transactionDate": "2021-03-09",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Self",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2021/8217977.pdf"
},
{
"symbol": "NBIX",
"senateID": "M001157",
"disclosureDate": "2021-04-19",
"transactionDate": "2021-03-09",
"firstName": "Michael T.",
"lastName": "McCaul",
"office": "Michael McCaul",
"district": "TX10",
"owner": "Joint",
"assetDescription": "Neurocrine Biosciences Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2021/8217977.pdf"
}
],
"dark_pool": [
{
"ticker": "NBIX",
"executed_at": "2026-10-19T15:43:04.827000Z",
"size": 900.0,
"price": 136.0099,
"premium": 122408.90999999999,
"volume": 900.0,
"trade_code": " "
},
{
"ticker": "NBIX",
"executed_at": "2026-10-19T15:45:15.122000Z",
"size": 210.0,
"price": 136.035,
"premium": 28567.35,
"volume": 210.0,
"trade_code": " "
},
{
"ticker": "NBIX",
"executed_at": "2026-10-19T15:47:02.133000Z",
"size": 200.0,
"price": 136.02,
"premium": 27204.000000000004,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "NBIX",
"executed_at": "2026-10-19T15:45:24.091000Z",
"size": 200.0,
"price": 136.035,
"premium": 27207.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "NBIX",
"executed_at": "2026-10-19T15:45:15.032000Z",
"size": 200.0,
"price": 136.035,
"premium": 27207.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "NBIX",
"executed_at": "2026-10-19T15:43:23.989000Z",
"size": 200.0,
"price": 136.08,
"premium": 27216.000000000004,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "NBIX",
"executed_at": "2026-10-19T15:43:21.111000Z",
"size": 200.0,
"price": 135.905,
"premium": 27181.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "NBIX",
"executed_at": "2026-10-19T15:39:16.161000Z",
"size": 200.0,
"price": 135.72,
"premium": 27144.0,
"volume": 200.0,
"trade_code": " "
}
],
"ats": {
"symbol": "NBIX",
"date": "20261016",
"ats_volume": 0,
"total_volume": 287840,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20261016",
"ats_ratio": 0.0
},
{
"date": "20261015",
"ats_ratio": 0.0
},
{
"date": "20261014",
"ats_ratio": 0.0
},
{
"date": "20261013",
"ats_ratio": 0.0
},
{
"date": "20261012",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "NBIX",
"days": [
{
"date": "2026-10-19",
"close": 135.8,
"vwap": 135.87,
"volume": 236065,
"vwap_discount_pct": 0.05
},
{
"date": "2026-10-16",
"close": 135.71,
"vwap": 136.15,
"volume": 1127483,
"vwap_discount_pct": 0.32
},
{
"date": "2026-10-15",
"close": 136.95,
"vwap": 136.92,
"volume": 1379144,
"vwap_discount_pct": -0.02
},
{
"date": "2026-10-14",
"close": 135.91,
"vwap": 135.58,
"volume": 1506704,
"vwap_discount_pct": -0.24
},
{
"date": "2026-10-13",
"close": 135.13,
"vwap": 135.99,
"volume": 1568446,
"vwap_discount_pct": 0.63
}
],
"avg_vwap_discount_pct": 0.15,
"signal": "Neutral"
},
"options_flow": [],
"net_premium": {
"ticker": "NBIX",
"net_call_premium": "2410.00",
"net_put_premium": "470.00",
"call_premium": "16948.00",
"put_premium": "770.00",
"bullish_premium": "9829.00",
"bearish_premium": "7889.00",
"put_call_ratio": "0.0588235294117647058823529412",
"iv_rank": "51.8084",
"implied_move_perc": "0.085",
"gex_ratio": null,
"gex_net_change": null,
"gex_call": "10192.0254",
"gex_put": "-10590.3162",
"gex_net": -398.2908,
"gex_call_delta": "614726.7133",
"gex_put_delta": "-401391.9060",
"gex_date": "2026-10-19"
},
"hot_chains": [
{
"underlying_symbol": "NBIX",
"expires": "2026-11-20",
"open_interest": 16,
"option_type": "call",
"delta": 0.545508887551231,
"ask_volume": 8,
"last_price": "7.40",
"implied_volatility": "0.4406409860467122",
"gamma": 0.02128808684819135,
"avg_price": "7.4933333333333333333333333333",
"bid_volume": 7,
"nbbo_ask": "9.00",
"strike": "135",
"option_symbol": "NBIX261120C00135000",
"total_premium": "11240.00",
"iv": 0.461305678962934,
"volume": 15,
"nbbo_bid": "6.80"
},
{
"underlying_symbol": "NBIX",
"expires": "2026-11-20",
"open_interest": 10,
"option_type": "call",
"delta": 0.31382576512759,
"ask_volume": 6,
"last_price": "3.47",
"implied_volatility": "0.4225000544185457",
"gamma": 0.02182290016726694,
"avg_price": "3.5566666666666666666666666666",
"bid_volume": 0,
"nbbo_ask": "3.80",
"strike": "145",
"option_symbol": "NBIX261120C00145000",
"total_premium": "2134.00",
"iv": 0.402684738031446,
"volume": 6,
"nbbo_bid": "2.40"
},
{
"underlying_symbol": "NBIX",
"expires": "2026-11-20",
"open_interest": 16,
"option_type": "call",
"delta": 0.422956614434234,
"ask_volume": 1,
"last_price": "6.00",
"implied_volatility": "0.4340437099683411",
"gamma": 0.0242911909828409,
"avg_price": "6.1500",
"bid_volume": 3,
"nbbo_ask": "6.90",
"strike": "140",
"option_symbol": "NBIX261120C00140000",
"total_premium": "2460.00",
"iv": 0.399313336416516,
"volume": 4,
"nbbo_bid": "6.00"
},
{
"underlying_symbol": "NBIX",
"expires": "2026-11-20",
"open_interest": 21,
"option_type": "call",
"delta": 0.00639858775674253,
"ask_volume": 0,
"last_price": "0.11",
"implied_volatility": "0.563223249070896",
"gamma": 0.00087862240946017,
"avg_price": "0.11",
"bid_volume": 2,
"nbbo_ask": "3.50",
"strike": "200",
"option_symbol": "NBIX261120C00200000",
"total_premium": "22.00",
"iv": 0.507591003102647,
"volume": 2,
"nbbo_bid": "0.00"
},
{
"underlying_symbol": "NBIX",
"expires": "2026-11-20",
"open_interest": 302,
"option_type": "put",
"delta": -0.1688149696425511,
"ask_volume": 0,
"last_price": "1.50",
"implied_volatility": "0.451595848887032",
"gamma": 0.01328981573725435,
"avg_price": "1.50",
"bid_volume": 1,
"nbbo_ask": "2.50",
"strike": "120",
"option_symbol": "NBIX261120P00120000",
"total_premium": "150.00",
"iv": 0.469674697109108,
"volume": 1,
"nbbo_bid": "1.30"
},
{
"underlying_symbol": "NBIX",
"expires": "2027-01-15",
"open_interest": 32,
"option_type": "call",
"delta": 0.1357873602561013,
"ask_volume": 1,
"last_price": "1.30",
"implied_volatility": "0.3440094967120394",
"gamma": 0.00853937512045422,
"avg_price": "1.30",
"bid_volume": 0,
"nbbo_ask": "4.10",
"strike": "170",
"option_symbol": "NBIX270115C00170000",
"total_premium": "130.00",
"iv": 0.382221973288983,
"volume": 1,
"nbbo_bid": "0.00"
},
{
"underlying_symbol": "NBIX",
"expires": "2027-01-15",
"open_interest": 6,
"option_type": "call",
"delta": 0.2223031442449444,
"ask_volume": 1,
"last_price": "2.60",
"implied_volatility": "0.3470351684457345",
"gamma": 0.01151902693937633,
"avg_price": "2.60",
"bid_volume": 0,
"nbbo_ask": "4.80",
"strike": "160",
"option_symbol": "NBIX270115C00160000",
"total_premium": "260.00",
"iv": 0.38718179311791,
"volume": 1,
"nbbo_bid": "0.30"
},
{
"underlying_symbol": "NBIX",
"expires": "2027-01-15",
"open_interest": 31,
"option_type": "call",
"delta": 0.177458156367309,
"ask_volume": 1,
"last_price": "1.85",
"implied_volatility": "0.3452425764660004",
"gamma": 0.01004807884370804,
"avg_price": "1.85",
"bid_volume": 0,
"nbbo_ask": "2.20",
"strike": "165",
"option_symbol": "NBIX270115C00165000",
"total_premium": "185.00",
"iv": 0.387530697321053,
"volume": 1,
"nbbo_bid": "0.05"
}
],
"gamma_profile": {
"ticker": "NBIX",
"spot": 135.945,
"date": "2026-10-19",
"flip_point": 119.91,
"net_gex": -398.29,
"call_walls": [
{
"strike": 150.0,
"gex": 3309.54
},
{
"strike": 170.0,
"gex": 1236.94
},
{
"strike": 160.0,
"gex": 971.41
}
],
"put_walls": [
{
"strike": 145.0,
"gex": -1805.9
},
{
"strike": 160.0,
"gex": -1670.53
},
{
"strike": 150.0,
"gex": -1454.54
}
],
"by_strike": [
{
"strike": 75.0,
"call_gex": 0.51,
"put_gex": -0.05,
"net_gex": 0.45
},
{
"strike": 80.0,
"call_gex": 0.41,
"put_gex": -8.29,
"net_gex": -7.87
},
{
"strike": 85.0,
"call_gex": 0.7,
"put_gex": -0.59,
"net_gex": 0.11
},
{
"strike": 90.0,
"call_gex": 0.0,
"put_gex": -1.23,
"net_gex": -1.23
},
{
"strike": 95.0,
"call_gex": 0.8,
"put_gex": -2.13,
"net_gex": -1.32
},
{
"strike": 100.0,
"call_gex": 8.42,
"put_gex": -7.18,
"net_gex": 1.24
},
{
"strike": 105.0,
"call_gex": 1.47,
"put_gex": -2.78,
"net_gex": -1.31
},
{
"strike": 110.0,
"call_gex": 67.95,
"put_gex": -13.74,
"net_gex": 54.22
},
{
"strike": 115.0,
"call_gex": 30.51,
"put_gex": -9.69,
"net_gex": 20.82
},
{
"strike": 120.0,
"call_gex": 384.96,
"put_gex": -451.22,
"net_gex": -66.26
},
{
"strike": 125.0,
"call_gex": 40.06,
"put_gex": -1225.99,
"net_gex": -1185.93
},
{
"strike": 130.0,
"call_gex": 635.27,
"put_gex": -750.92,
"net_gex": -115.64
},
{
"strike": 135.0,
"call_gex": 571.85,
"put_gex": -1010.57,
"net_gex": -438.72
},
{
"strike": 140.0,
"call_gex": 599.88,
"put_gex": -1334.01,
"net_gex": -734.13
},
{
"strike": 145.0,
"call_gex": 627.47,
"put_gex": -1805.9,
"net_gex": -1178.43
},
{
"strike": 150.0,
"call_gex": 3309.54,
"put_gex": -1454.54,
"net_gex": 1855.0
},
{
"strike": 155.0,
"call_gex": 645.13,
"put_gex": -490.31,
"net_gex": 154.82
},
{
"strike": 160.0,
"call_gex": 971.41,
"put_gex": -1670.53,
"net_gex": -699.13
},
{
"strike": 165.0,
"call_gex": 92.62,
"put_gex": -273.88,
"net_gex": -181.26
},
{
"strike": 170.0,
"call_gex": 1236.94,
"put_gex": -56.32,
"net_gex": 1180.62
},
{
"strike": 175.0,
"call_gex": 112.96,
"put_gex": -9.53,
"net_gex": 103.42
},
{
"strike": 180.0,
"call_gex": 32.95,
"put_gex": -0.44,
"net_gex": 32.52
},
{
"strike": 185.0,
"call_gex": 44.08,
"put_gex": -10.41,
"net_gex": 33.66
},
{
"strike": 190.0,
"call_gex": 306.15,
"put_gex": 0.0,
"net_gex": 306.15
},
{
"strike": 195.0,
"call_gex": 56.34,
"put_gex": 0.0,
"net_gex": 56.34
}
]
},
"oi_changes": {
"net_call_oi_change": 0,
"net_put_oi_change": 0,
"top": [
{
"strike": "150",
"oi_change": 0,
"type": "call"
},
{
"strike": "170",
"oi_change": 0,
"type": "call"
},
{
"strike": "160",
"oi_change": 0,
"type": "put"
},
{
"strike": "145",
"oi_change": 0,
"type": "put"
},
{
"strike": "125",
"oi_change": 0,
"type": "put"
}
]
},
"opds": {
"opds": 2.9,
"D": 14.6,
"P": -46.0,
"O": -16.7,
"C": 20.0,
"signal": "NEUTRAL",
"direction": "bullish",
"coverage": 0.5,
"ranked": true,
"components": {
"M": -21.8,
"T": -70.8,
"RS": -95.5,
"V": -7.7,
"F": 10.9,
"OI": null,
"S": -100.0,
"IV": null,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": null,
"FlowAgreement": 50.0,
"StrikeBreadth": null
},
"drivers": [
"- skew -100",
"- relative strength -96",
"- trend -71",
"- momentum -22"
]
}
}
Data:
{
"vix": 16.87,
"sp500": 7718.94,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.37,
"hy_spread": 3.16,
"treasury": {
"date": "2026-10-16",
"month1": 4.12,
"month2": 4.17,
"month3": 4.26,
"month6": 4.34,
"year1": 4.46,
"year2": 4.74,
"year3": 4.82,
"year5": 4.89,
"year7": 4.98,
"year10": 5.09,
"year20": 5.47,
"year30": 5.43
},
"events": []
}
Data:
{
"days": 103,
"patterns": [
{
"name": "VWAP Touch",
"count": 103,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 97,
"pct": 94
},
{
"name": "Woodie Pivot Touch",
"count": 96,
"pct": 93
},
{
"name": "PDH/PDL Touch",
"count": 88,
"pct": 85
},
{
"name": "Open Retracement",
"count": 78,
"pct": 76
},
{
"name": "Gap Fill",
"count": 77,
"pct": 75
},
{
"name": "Darvas Box",
"count": 20,
"pct": 19
},
{
"name": "High Vol Open",
"count": 19,
"pct": 18
},
{
"name": "Power Hour",
"count": 8,
"pct": 8
}
]
}